Squarepoint
UNCY icon

Squarepoint’s Unicycive Therapeutics UNCY Stock Holding History

Squarepoint’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$122K Buy
+25,881
New +$134K ﹤0.01% 4179
2026
Q1 		– Sell
-55,305
Closed -$319K – 5005
2025
Q4 		$319K Sell
55,305
-62,022
-53% -$331K ﹤0.01% 3555
2025
Q3 		$512K Buy
+117,327
New +$511K ﹤0.01% 3216
2023
Q2 		– Sell
-1,146
Closed -$24.1K – 4035
2023
Q1 		$24.1K Buy
+1,146
New +$11.4K ﹤0.01% 3117

Other funds holding UNCY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Chicago Partners Investment Group
Chicago Partners Investment Group Chicago, Illinois $5.45B AUM 19.52% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Great Valley Advisor Group
Great Valley Advisor Group Wilmington, Delaware $6.91B AUM 16.83% 1-Year Est. Return
Macroview Investment Management
Macroview Investment Management Bethesda, Maryland $167M AUM 15.37% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Squarepoint's UNCY Position: Q3 2026 in Review

Squarepoint opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 25,881 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #4179 among its holdings. This is a return to the name: Squarepoint previously reported a position in UNCY as recently as Q4 2025.

Squarepoint first reported a position in UNCY in Q1 2023 and has held it in 4 quarters since. The position peaked at $512K in Q3 2025. 34 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

  • Squarepoint held 25,881 shares of Unicycive Therapeutics worth $122K as of Q3 2026.
  • Unicycive Therapeutics was a new Squarepoint position in Q3 2026.
  • Unicycive Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4179 holding.
  • Squarepoint first reported a position in Unicycive Therapeutics in Q1 2023 and has held it in 4 quarters since.
  • Squarepoint's Unicycive Therapeutics position peaked at $512K in Q3 2025.
  • 34 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.